Search Results 1771-1780 of 19149 for Enzyme

1. Cellular Immunotherapy in Recipients of HLA-matched, Living Donor Kidney Transplants - Mayo Clinic

   Participants with negative anti-HCV antibodies but unexplained liver enzyme abnormalities must undergo a quantitative serum RNA assay to rule out false negative ...

2. AKT Inhibitor MK2206, Combined with Bendamustine Hydrochloride, and Rituximab for Treating Patients who have Relapsed Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma - Mayo Clinic

   Akt inhibitor MK2206 may stop the growth of cancer cells by blocking some of the enzymes needed for cell growth. Drugs used in chemotherapy, such as ...

3. A Phase II, Single Arm Study of BGJ398 in Patients With Advanced Cholangiocarcinoma - Mayo Clinic

   Patients are not permitted to receive enzyme-inducing anti-epileptic drugs. Consumption of grapefruit, grapefruit juice, grapefruit hybrids, pomegranates ...

4. Consortium improves cardiogenic shock outcomes across southeast - Mayo Clinic

   For smaller hospitals, this includes simple steps such as teaching teams to check three key labs — lactate, creatinine and liver enzymes — whenever a patient is ...

5. Ixabepilone and Temsirolimus in Treating Patients with Solid Tumors that are Metastatic or Cannot ce Removed by Surgery - Mayo Clinic

   Temsirolimus may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Giving ixabepilone together with temsirolimus may ...

6. Testing the Effect of M1774 on Hard-to-Treat Refractory SPOP-mutant Prostate Cancer - Mayo Clinic

   M1774 may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Participation eligibility. Participant eligibility includes ...

7. Removal of 'zombie cells' alleviates causes of diabetes in obese mice - Mayo Clinic News Network

   — Mayo Clinic researchers and their collaborators have shown that when senescent cells — also known as “zombie cells” — are removed from fat tissue in obese ...

8. Atidarsagene autotemcel (intravenous route) - Side effects & uses - Mayo Clinic

   Metachromatic leukodystrophy (MLD) is a rare genetic disorder that affects the brain and nervous system caused by a deficiency of an enzyme called arylsulfatase ...

9. Testing the Addition of Ixazomib to Lenalidomide in Patients With Evidence of Residual Multiple Myeloma, OPTIMUM Trial - Mayo Clinic

   Ixazomib may stop the growth of cancer cells by blocking some of the enzymes needed for cell growth. Giving lenalidomide and ixazomib together may work ...

10. Azacitidine With or Without Nivolumab or Midostaurin, or Decitabine and Cytarabine Alone in Treating Older Patients With Newly Diagnosed Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome - Mayo Clinic

    Midostaurin may stop the growth of cancer cells by blocking some of the enzymes needed for cell growth. Giving azacitidine with or without nivolumab or ...